CD8A and lung carcinoma: The tumor progress in mice receiving adoptively transferred CD8+ T cells from A2-5/Th/CpG/ISA immunized mice was reduced significantly as compared to the control group (Figure 4B), indicating anti-tumor activity of peptide A2-5 immunized CD8+ CTL cells against human lung cancer cells in vivo.